Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

被引：0
|
作者：
Roisin Adams
Cathal Walsh
Douglas Veale
Barry Bresnihan
Oliver FitzGerald
Michael Barry
机构：
[1] St. James’ Hospital,National Centre for Pharmacoeconomics
[2] Trinity College Dublin,Department of Statistics
[3] Dublin Academic Healthcare,St. Vincent’s University Hospital
来源：
PharmacoEconomics | 2010年 / 28卷
关键词：
Rheumatoid Arthritis; Inflammatory Arthritis; Biological Therapy; Utility Score; Disease Activity Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The growth of economic analyses and in particular cost-utility analyses (CUA), which use the QALY as a measure of outcome, has heightened the interest in the methodologies used to calculate the QALY. The EQ-5D has produced quite different utility values from that of the SF-6D. This article seeks to understand these differences using a cohort of patients with inflammatory arthritis.
引用
收藏
页码：477 / 487
页数：10
相关论文
共 50 条
  • [1] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Adams, Roisin
    Walsh, Cathal
    Veale, Douglas
    Bresnihan, Barry
    FitzGerald, Oliver
    Barry, Michael
    PHARMACOECONOMICS, 2010, 28 (06) : 477 - 487
  • [2] A CALIBRATION OF THE RELATIONSHIP BETWEEN THE HAQ, THE SF-6D AND THE EQ-5D IN INFLAMMATORY ARTHRITIS
    Adams, R.
    Walsh, C.
    Tilson, L.
    FitzGerald, O.
    Bresnihan, B.
    Veale, D.
    Barry, M.
    VALUE IN HEALTH, 2009, 12 (07) : A446 - A447
  • [3] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    M. J. Harrison
    L. M. Davies
    N. J. Bansback
    M. J. McCoy
    S. M. M. Verstappen
    K. Watson
    D. P. M. Symmons
    Quality of Life Research, 2009, 18 : 1195 - 1205
  • [4] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    Harrison, M. J.
    Davies, L. M.
    Bansback, N. J.
    McCoy, M. J.
    Verstappen, S. M. M.
    Watson, K.
    Symmons, D. P. M.
    QUALITY OF LIFE RESEARCH, 2009, 18 (09) : 1195 - 1205
  • [5] Comparison of EQ-5D and SF-6D utilities in Pompe disease
    Kanters, T. A.
    Redekop, W. K.
    Kruijshaar, M. E.
    van der Ploeg, A. T.
    Rutten-van Molken, M. P. M. H.
    Hakkaart, L.
    QUALITY OF LIFE RESEARCH, 2015, 24 (04) : 837 - 844
  • [6] Comparison of EQ-5D and SF-6D utilities in Pompe disease
    T. A. Kanters
    W. K. Redekop
    M. E. Kruijshaar
    A. T. van der Ploeg
    M. P. M. H. Rutten-van Mölken
    L. Hakkaart
    Quality of Life Research, 2015, 24 : 837 - 844
  • [7] COMPARISON OF EQ-5D AND SF-6D UTILITIES IN POMPE DISEASE
    Kanters, T.
    Redekop, W.
    Hagemans, M. L. C.
    Van der Ploeg, A. T.
    Rutten-van Moelken, M. P.
    Hakkaart, L.
    VALUE IN HEALTH, 2011, 14 (07) : A418 - A418
  • [8] Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
    Henk F van Stel
    Erik Buskens
    Health and Quality of Life Outcomes, 4
  • [9] Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
    van Stel, Henk F.
    Buskens, Erik
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
  • [10] COMPARISON OF THE SF-6D AND THE EQ-5D IN PATIENTS WITH SCHIZOPHRENIA
    Millier, A.
    Perthame, E.
    Aballea, S.
    Toumi, M.
    VALUE IN HEALTH, 2011, 14 (07) : A294 - A294
12345